about
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry.Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma.Abiraterone-induced rhabdomyolysis resulting in acute kidney injury: A case report and review of the literature.Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690.Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy.Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma.Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.Current perspectives on Mohs micrographic surgery for melanoma.Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model
P2860
Q37702662-01BDE571-ECB2-4582-BB48-D6ECC738CD41Q38738044-570F11C1-D4B2-48AE-9F3A-143FB34EA1D5Q38781322-DE45627C-68B6-4DEE-895C-10EDF0D850F4Q39207082-C570DFEF-76EC-4779-8096-16ADD3ACF9B7Q40494079-1445FC7E-1817-49DA-8F3E-2E052C54A070Q47437708-F8AAC995-F945-41B5-B484-F37B9A1B64DCQ47669815-D18C2545-16C5-4B91-BA00-D37F1AD97089Q47692272-5BEAE9FF-D85D-4BFD-BEB5-80A3BE96942CQ48514183-B6C65402-61FB-4329-AA36-D77C9B4B4CEEQ49464812-BB1D9B4F-0F4E-4DDF-B4DB-35562403416DQ49887971-2E02198F-CD10-4E5A-BB5A-A00DDE686959Q55356679-086CB507-A298-4850-8025-0EA4EE303FF5Q56876196-F7B75F10-4825-4410-8219-36CE5B35AFCA
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@en
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@nl
type
label
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@en
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@nl
prefLabel
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@en
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@nl
P2093
P356
P1476
NCCN Guidelines Insights: Melanoma, Version 3.2016.
@en
P2093
Alain Algazi
Anita Engh
Anthony J Olszanski
Aparna Priyanath Gupta
April K Salama
Brian Gastman
Christopher K Bichakjian
Daniel G Coit
Dominick DiMaio
Douglas Johnson
P304
P356
10.6004/JNCCN.2016.0101
P577
2016-08-01T00:00:00Z